GERN Q2 2017 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena

GERNGeron Corporation

$1B

Q2 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$174,000-17.5% YoY

Gross Profit

-$2M-954.6% margin

Operating Income

-$7M-3868.4% margin

Net Income

-$6M-3681.0% margin

EPS (Diluted)

$-0.04

QoQ Revenue Growth

-67.6%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$124M

Total Liabilities

$11M

Stockholders' Equity

$113M

Cash & Equivalents

$7M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$174,000	$211,000	-17.5%
Gross Profit	-$2M	-$3M	+52.0%
Operating Income	-$7M	-$9M	+24.5%
Net Income	-$6M	-$9M	+25.8%